‘Who Is The Arbiter?’ US FDA Asks As It Mulls Loosening Off-Label Reins

A drumbeat of court cases – and now a change in presidential administrations – signals that regulations on off-label communications need to change; but FDA still seems unsure how to relax its grip without letting go completely.